MedTrace Logo

Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia

NCT01138306 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 149

Last updated 2016-05-18

No results posted yet for this study

Summary

RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about biomarkers related to cancer.

PURPOSE: This research study is studying biomarkers in samples from young patients with acute myeloid leukemia.

Conditions

Interventions

GENETIC

gene expression analysis

GENETIC

mutation analysis

OTHER

flow cytometry

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Phoenix Ho, MD · Fred Hutchinson Cancer Center

Eligibility

Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2016-05-31
Completion
2016-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01138306 on ClinicalTrials.gov